Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients

1 min read

The FDA approved Mounjaro to reduce the risk of heart attack, stroke and cardiovascular death in certain adults with type 2 diabetes.


Sources: 9News (Denver TV station)

More in front range